BELLEVUE, Wash.--(BUSINESS WIRE)--Today, Viome, a longevity company committed to translating scientific advancements into practical and individualized health solutions, has announced the introduction ...

Viome's Full Body Intelligence Test ™ is the only science backed at-home test that decodes your body's biological signals to give you precision health insights. It reveals not just what's happening ...

Viome Life Sciences, a genomic testing company, has raised $67 million in a series C funding round. The round was led by Bold Capital Group alongside existing investors Khosla Ventures, WestRiver ...

A collaboration between Viome Life Sciences and Scripps Research is set to develop and clinically validate the first ribonucleic acid (RNA) test aimed at detecting precancerous colon polyps. This ...

Biotechnology company Viome Life Sciences will be expanding its development of direct-to-consumer diagnostic tests and wellness products after receiving $67 million in series C funding, the startup ...

Built on unique RNA science and cutting-edge AI, Viome's at-home test redefines health by analyzing 100 million biomarkers to detect early signs of biological dysfunction linked to 25+ chronic health ...